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Intra-individual changes in methylome proﬁles: an epigenetic
‘scar’ of early-life adversity?
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Whereas genetics plays a critical role in vulnerability and resilience
to mental illness, the contribution of early-life experiences to these
outcomes has been strongly suggested in humans and supported
by studies in animal models [1]. Early-life adversity (ELA), including
poverty, chaotic environment, and abuse, predicts vulnerability to
depression as well as lower cognitive function [1, 2]. Yet, at the
individual level it is not possible to predict which child exposed to
ELA will be vulnerable later in life. Lacking are predictive biomarkers
that enable early diagnosis, prevention, and intervention [1–3].
There is evidence that the mechanisms by which early-life
experiences inﬂuence the function of neurons (and neuronal
networks) underlying vulnerability or resilience involve alterations
of the repertoire and levels of gene expression via epigenetic
processes. Among those, changes in DNA methylation at the
individual gene and genomic scale may partially govern gene
expression. It is not possible to examine DNA from brain samples
in children, so that current approaches have largely employed
peripheral cells including white blood cells or buccal swabs (mixed
epithelial/white blood cells). Numerous studies have compared
DNA methylation proﬁles from individuals experiencing adversity
to those raised in ‘typical’ environments; yet cross-sectional
studies are challenged by the large inter-individual variance of
DNA methylation proﬁles.
We employed a novel intra-individual approach by testing
buccal cell DNA methylation proﬁles of the same individual
sampled twice: immediately before and after a deﬁned period of
ELA [3]. We imposed ELA of deﬁned onset and termination during
established sensitive developmental periods by raising rat pups
for a week (postnatal days 2–10) in cages with limited bedding
and nesting materials (simulated poverty). Prior work established
that this experience provokes enduring anhedonia-like behaviors
and signiﬁcant deﬁcits in hippocampus-dependent memory [4, 5].
Controls were sampled in parallel.
Traditional analyses of DNA methylation proﬁles across samples
detected the effects of age, but did not distinguish pups exposed
to ELA from controls. In contrast, DNA methylation changes
between paired DNA samples from the same individual rat
illustrated the impact of ELA. In ELA animals, methylation
increased (predicting reduced expression) in genes coding for
critical cellular/metabolic enzymes, ion channels, and receptors,
whereas genes involved in pathways of death, inﬂammation, and
cell-fate were less methylated, indicating their potential upregula-
tion [3]. Thus ELA left an epigenetic ‘signature’: large-scale
transcription-driven alterations of cellular fate, growth and
function, consistent with –and potentially predicting–pathology.
This work, employing rodents, provides proof of principle for
the potential power of intra-individual methylomics to identify
epigenetic signatures of ELA which predict subsequent emotional
and memory problems. The approach is translatable to the clinic
[5, 6], as methylomic signatures in individual children might
predict vulnerability or resilience to stress and/or mental illness.
Current studies in infants are obtaining buccal-swab DNA twice,
during the second week of life and at 1 year. ELA, derived from
unpredictable environmental and maternal signals [5, 6] is
assessed, and cognitive and emotional outcomes of individual
infants are examined longitudinally.
In summary, intra-individual methylomics identiﬁes epigenetic
‘scars’ and ‘kisses’ of early adversity, which may provide a predictive
marker for vulnerability and resilience to certain mental illnesses.
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